{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:50:53Z","timestamp":1792479053908,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-04062-y","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:53:27Z","timestamp":1736268807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model"],"prefix":"10.1186","volume":"16","author":[{"given":"Fatemeh","family":"Kheradmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Fatemeh","family":"Yasaman Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad Sahab","family":"Negah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh Kaffash","family":"Farkhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Elnaz","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hajinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Khodadoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsane","family":"Fadaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil Tavakol","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"4062_CR1","doi-asserted-by":"crossref","unstructured":"Mao F et al. Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. BioMed Res Int. 2017;2017.","DOI":"10.1155\/2017\/5356760"},{"issue":"4","key":"4062_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.pharep.2016.05.002","volume":"68","author":"JA Uranga","year":"2016","unstructured":"Uranga JA, et al. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep. 2016;68(4):816\u201326.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4062_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13287-021-02404-8","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther. 2021;12(1):315.","journal-title":"Stem Cell Res Ther"},{"issue":"10114","key":"4062_CR4","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378.","journal-title":"Lancet"},{"issue":"2","key":"4062_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/apt.13864","volume":"45","author":"C Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire C, et al. Mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45(2):205\u201321.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"4062_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, et al. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747\u201354.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"4062_CR7","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1097\/MIB.0000000000000543","volume":"21","author":"M Dave","year":"2015","unstructured":"Dave M, et al. Mesenchymal stem cell therapy for inflammatory bowel disease: a systematic review and Meta-analysis. Inflamm Bowel Dis. 2015;21(11):2696\u2013707.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"4062_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes GM, et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014;12(1):64\u201371.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4062_CR9","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1002\/jcb.28376","volume":"120","author":"T Ma","year":"2019","unstructured":"Ma T, et al. Adipose mesenchymal stem cell-derived exosomes promote cell proliferation, migration, and inhibit cell apoptosis via Wnt\/\u03b2\u2010catenin signaling in cutaneous wound healing. J Cell Biochem. 2019;120(6):10847\u201354.","journal-title":"J Cell Biochem"},{"key":"4062_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.03.022","volume":"206","author":"J Wu","year":"2019","unstructured":"Wu J, et al. Mir-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206:87\u2013100.","journal-title":"Biomaterials"},{"issue":"6","key":"4062_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"4062_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138.","journal-title":"Stem Cells"},{"key":"4062_CR13","doi-asserted-by":"publisher","first-page":"1107150","DOI":"10.3389\/fimmu.2023.1107150","volume":"14","author":"B Weber","year":"2023","unstructured":"Weber B, et al. Release of exosomes in polytraumatized patients: the injury pattern is reflected by the surface epitopes. Front Immunol. 2023;14:1107150.","journal-title":"Front Immunol"},{"key":"4062_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.reth.2022.03.006","volume":"20","author":"NK Farkhad","year":"2022","unstructured":"Farkhad NK, Mahmoudi A, Mahdipour E. Regenerative Therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms. Regenerative Therapy. 2022;20:61\u201371.","journal-title":"Regenerative Therapy"},{"key":"4062_CR15","doi-asserted-by":"crossref","unstructured":"Liu H et al. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight, 2019. 4(24).","DOI":"10.1172\/jci.insight.131273"},{"issue":"8","key":"4062_CR16","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1002\/jcp.30275","volume":"236","author":"N Heidari","year":"2021","unstructured":"Heidari N, et al. Adipose-derived mesenchymal stem cell\u2010secreted exosome alleviates dextran sulfate sodium\u2010induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 2021;236(8):5906\u201320.","journal-title":"J Cell Physiol"},{"key":"4062_CR17","doi-asserted-by":"publisher","first-page":"749192","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, et al. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12:749192.","journal-title":"Front Immunol"},{"key":"4062_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejpb.2021.07.014","volume":"167","author":"PM Veloso","year":"2021","unstructured":"Veloso PM, Machado R, Nobre C. Mesalazine and inflammatory bowel disease\u2013from well-established therapies to progress beyond the state of the art. Eur J Pharm Biopharm. 2021;167:89\u2013103.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"4062_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3109\/00365521.2015.1018937","volume":"50","author":"\u00d8 Hauso","year":"2015","unstructured":"Hauso \u00d8, Martinsen TC, Waldum H. 5-Aminosalicylic acid, a specific drug for ulcerative colitis. Scand J Gastroenterol. 2015;50(8):933\u201341.","journal-title":"Scand J Gastroenterol"},{"key":"4062_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40262-018-0676-z","volume":"58","author":"SE Berends","year":"2019","unstructured":"Berends SE, et al. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of ulcerative colitis. Clin Pharmacokinet. 2019;58:15\u201337.","journal-title":"Clin Pharmacokinet"},{"issue":"10\u201311","key":"4062_CR21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.intimp.2004.06.002","volume":"4","author":"W Auttachoat","year":"2004","unstructured":"Auttachoat W, et al. Immunomodulation by Dok Din Daeng (Aeginetia indica Roxb.) Extracts in female B6C3F1 mice:(I): stimulation of T cells. Int Immunopharmacol. 2004;4(10\u201311):1367\u201379.","journal-title":"Int Immunopharmacol"},{"key":"4062_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12015-017-9789-2","volume":"14","author":"BS Markovic","year":"2018","unstructured":"Markovic BS, et al. Molecular and cellular mechanisms involved in mesenchymal stem cell-based therapy of inflammatory bowel diseases. Stem Cell Reviews Rep. 2018;14:153\u201365.","journal-title":"Stem Cell Reviews Rep"},{"key":"4062_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02492-6","volume":"12","author":"X Cai","year":"2021","unstructured":"Cai X, et al. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p\/NLRP3 axis. Stem Cell Res Ther. 2021;12:1\u201316.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4062_CR24","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.3390\/ijms22126431","volume":"22","author":"L-J Tak","year":"2021","unstructured":"Tak L-J, et al. Superoxide dismutase 3-transduced mesenchymal stem cells preserve epithelial tight junction barrier in murine colitis and attenuate inflammatory damage in epithelial organoids. Int J Mol Sci. 2021;22(12):6431.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4062_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.15283\/ijsc18139","volume":"12","author":"ZJ Ma","year":"2019","unstructured":"Ma ZJ, et al. Immunosuppressive effect of exosomes from mesenchymal stromal cells in defined medium on experimental colitis. Int J stem Cells. 2019;12(3):440\u20138.","journal-title":"Int J stem Cells"},{"key":"4062_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-017-0735-7","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, et al. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4\/NF-\u03baB signaling pathway in vivo and in vitro. Stem Cell Res Ther. 2018;9:1\u201314.","journal-title":"Stem Cell Res Ther"},{"key":"4062_CR27","doi-asserted-by":"crossref","unstructured":"Sun Q et al. hUC-MSCs therapy for Crohn\u2019s disease: efficacy in TNBS-induced colitis in rats and pilot clinical study. Ebiomedicine, 2024. 103.","DOI":"10.1016\/j.ebiom.2024.105128"},{"issue":"1","key":"4062_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10565-024-09921-1","volume":"40","author":"X Xu","year":"2024","unstructured":"Xu X, et al. hucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the METTL3-Slc37a2-YTHDF1 axis. Cell Biol Toxicol. 2024;40(1):74.","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"4062_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ymthe.2017.09.023","volume":"26","author":"S-R Park","year":"2018","unstructured":"Park S-R, et al. Stem cell secretome and its effect on cellular mechanisms relevant to wound healing. Mol Ther. 2018;26(2):606\u201317.","journal-title":"Mol Ther"},{"issue":"7","key":"4062_CR30","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.3390\/ijms22073576","volume":"22","author":"S Fern\u00e1ndez-Francos","year":"2021","unstructured":"Fern\u00e1ndez-Francos S, et al. Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine. Int J Mol Sci. 2021;22(7):3576.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4062_CR31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/pharmaceutics13081127","volume":"13","author":"J Sendon-Lago","year":"2021","unstructured":"Sendon-Lago J, et al. Tailored hydrogels as delivery platforms for conditioned medium from mesenchymal stem cells in a model of acute colitis in mice. Pharmaceutics. 2021;13(8):1127.","journal-title":"Pharmaceutics"},{"key":"4062_CR32","doi-asserted-by":"crossref","unstructured":"Wang S et al. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics. Int J Nanomed, 2022: pp. 1757\u201381.","DOI":"10.2147\/IJN.S355366"},{"key":"4062_CR33","doi-asserted-by":"publisher","first-page":"952071","DOI":"10.3389\/fimmu.2022.952071","volume":"13","author":"Z Che","year":"2022","unstructured":"Che Z, et al. Mesenchymal stem\/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases. Front Immunol. 2022;13:952071.","journal-title":"Front Immunol"},{"issue":"8","key":"4062_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2174\/22123946MTE0cNjc70","volume":"16","author":"NK Farkhad","year":"2021","unstructured":"Farkhad NK, Mahmoudi A, Mahdipour E. How similar are human mesenchymal stem cells derived from different origins? A review of comparative studies. Curr Stem Cell Res Therapy. 2021;16(8):980\u201393.","journal-title":"Curr Stem Cell Res Therapy"},{"key":"4062_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.reth.2021.05.007","volume":"18","author":"NK Farkhad","year":"2021","unstructured":"Farkhad NK, et al. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regenerative Therapy. 2021;18:152\u201360.","journal-title":"Regenerative Therapy"},{"issue":"1","key":"4062_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","volume":"13","author":"N Kaffash Farkhad","year":"2022","unstructured":"Kaffash Farkhad N, et al. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial. Stem Cell Res Ther. 2022;13(1):283.","journal-title":"Stem Cell Res Ther"},{"key":"4062_CR37","unstructured":"Farkhad NK et al. Specific clinical and immunological changes following mesenchymal stem cell transplantation in COVID-19\u2013induced Acute Respiratory Distress Syndrome patients: a Phase-I clinical trial. Iran J Allergy Asthma Immunol, 2022: pp. 1\u201317."},{"key":"4062_CR38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12015-014-9583-3","volume":"11","author":"M Gazdic","year":"2015","unstructured":"Gazdic M, et al. Mesenchymal stem cells: a friend or foe in immune-mediated diseases. Stem Cell Reviews Rep. 2015;11:280\u20137.","journal-title":"Stem Cell Reviews Rep"},{"issue":"1","key":"4062_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13287-021-02363-0","volume":"12","author":"D Zheng","year":"2021","unstructured":"Zheng D, et al. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 2021;12(1):299.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4062_CR40","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1002\/ctm2.113","volume":"10","author":"G Wang","year":"2020","unstructured":"Wang G, et al. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med. 2020;10(2):e113.","journal-title":"Clin Transl Med"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-04062-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:04:32Z","timestamp":1736269472000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-04062-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4062"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-04062-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"18 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed following the Declaration of Helsinki Ethical Principles and approved by the Ethics Committee of the Mashhad University of Medical Sciences, Mashhad, Iran (IR. MUMS. RES.1401.133). (1) Title of the approved project: Evaluation of the effectiveness of umbilical cord mesenchymal stem cells along with the synergistic effect of the Exosomes derived from them on the immune response of an IBD mouse model. (2) Name of the institutional approval committee: the Ethics Committee of the Mashhad University of Medical Sciences, Mashhad, Iran. (3) Approval number: IR. MUMS. RES.1401.133. (4) Date of approval: 06\/08\/2022. After filling out the informed consent letter, human umbilical cords (H-UC) were obtained from Imam Reza hospital from full-term pregnancy mothers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}